Morphofunctional characteristics of skeletal muscle in rats with cerebral palsy-Reference-Cited by-同舟云学术

Morphofunctional characteristics of skeletal muscle in rats with cerebral palsy

Published:2019-02 Issue:1 Volume:100 Page:49-59
ISSN:0959-9673
Container-title:International Journal of Experimental Pathology
language:en
Short-container-title:Int. J. Exp. Path.

Author:

Buratti Pâmela¹^ORCID,Covatti Caroline¹,Centenaro Lígia Aline²,Brancalhão Rose Meire Costa¹,Torrejais Marcia Miranda¹

Affiliation:

1. Programa de Pós‐Graduação em Biociências e SaúdeUniversidade Estadual do Oeste do Paraná ‐ UNIOESTE Cascavel Paraná Brazil

2. Centro de Ciências Médicas e FarmacêuticasUniversidade Estadual do Oeste do Paraná ‐ UNIOESTE Cascavel Paraná Brazil

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iep.12304

Reference70 articles.

1. A report: the definition and classification of cerebral palsy April 2006;Rosenbaum P;Dev Med Child Neurol,2007

2. Efficacy of botulinum toxin A in children with cerebral palsy in Gross Motor Function Classification System levels IV and V: a systematic review

3. Desempenho funcional em crianças com paralisia cerebral;Souza MF;Rev Cient Faminas,2013

4. Paralisia cerebral: causas e prevalências;Zanini G;Fisioter Mov,2009

5. Brasil.Ministério da Saúde. Diretrizes de atenção à pessoa com paralisia cerebral. Secretaria da Atenção à Saúde – Departamento de Ações Programáticas Estratégicas Brasília – 2013.2013.http://bvsms.saude.gov.br/bvs/publicacoes/diretrizes_atencao_paralisia_cerebral.pdf. Acessed in April 3 2017.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neonatal treatment with fluoxetine alters locomotor activity and the cortical glial/neuron index in rats with cerebral palsy;Canadian Journal of Physiology and Pharmacology;2023-07-01

2. Neonatal treatment with fluoxetine alters locomotor activity and the cortical glial/neuron index in rats with cerebral palsy;CAN J PHYSIOL PHARM;2023

3. Experimental cerebral palsy in animals and developmental plasticity;Handbook of Animal Models in Neurological Disorders;2023

4. The spa transgenic mouse model of hypertonia and use for studying cerebral palsy;Handbook of Animal Models in Neurological Disorders;2023

5. l-2-Hydroxyglutaric Acid Administration to Neonatal Rats Elicits Marked Neurochemical Alterations and Long-Term Neurobehavioral Disabilities Mediated by Oxidative Stress;Neurotoxicity Research;2022-12-29